ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
TG Therapeutics Inc

TG Therapeutics Inc (TGTX)

14.25
0.15
(1.06%)
Closed April 23 4:00PM
14.36
0.11
( 0.77% )
Pre Market: 7:16AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
14.36
Bid
14.20
Ask
14.31
Volume
335
0.00 Day's Range 0.00
6.46 52 Week Range 35.67
Market Cap
Previous Close
14.25
Open
-
Last Trade
86
@
14.31
Last Trade Time
07:17:25
Financial Volume
-
VWAP
-
Average Volume (3m)
3,494,651
Shares Outstanding
154,420,772
Dividend Yield
-
PE Ratio
173.57
Earnings Per Share (EPS)
0.08
Revenue
233.66M
Net Profit
12.67M

About TG Therapeutics Inc

TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is developing two therapies targeting hematologic malignancies. TG-1101 (ublituximab) is a novel, ... TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is developing two therapies targeting hematologic malignancies. TG-1101 (ublituximab) is a novel, glycoengineered monoclonal antibody that targets a unique epitope on the CD20 antigen found on mature B-lymphocytes. It is also developing TGR-1202 (umbralisib), an orally available PI3K delta inhibitor. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
TG Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TGTX. The last closing price for TG Therapeutics was $14.25. Over the last year, TG Therapeutics shares have traded in a share price range of $ 6.46 to $ 35.67.

TG Therapeutics currently has 154,420,772 shares outstanding. The market capitalization of TG Therapeutics is $2.20 billion. TG Therapeutics has a price to earnings ratio (PE ratio) of 173.57.

TG Therapeutics (TGTX) Options Flow Summary

Overall Flow

Bearish

Net Premium

-1M

Calls / Puts

33.33%

Buys / Sells

150.00%

OTM / ITM

26.32%

Sweeps Ratio

0.00%

TGTX Latest News

TG Therapeutics Announces Additional Data Presentations for BRIUMVIยฎ (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating...

TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis

NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced that it has been awarded a national contract with the Department of Veterans Affairs (VA) for...

TG Therapeutics Announces Presentation of Data for BRIUMVIยฎ (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I & II Phase 3 trials evaluating...

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVIยฎ (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data from the ULTIMATE I & II Phase 3...

TG Therapeutics Announces Presentation of Data for BRIUMVIยฎ in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I & II Phase 3 trials and the ENHANCE Phase 3b...

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results

Fourth quarter and full year 2023 BRIUMVI U.S. net revenue of approximately $40 million and $89 million, respectively Conference call to be held today, February 28, 2024, at 8:30 AM ETย ย ย  NEW...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.32.1337126600314.0614.6313.26314288413.97702531CS
4-1.19-7.6527331189715.5515.61513.26256026914.40770732CS
12-1.74-10.807453416116.119.017512.84349465115.38983118CS
267.59112.112259976.7722.676.77502070314.41885618CS
52-7.86-35.373537353722.2235.676.46478690315.90289467CS
156-28.5-66.495566962242.8645.53.48346585714.62340337CS
2606.2376.62976629778.1356.743.48276654316.33696302CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.253
(66.12%)
9.76M
ZPTAZapata Computing Holdings Inc
$ 1.99
(27.56%)
5.11M
IMCCIM Cannabis Corporation
$ 0.7268
(27.44%)
7
TSLRGraniteShares ETF Trust GraniteShares
$ 10.15
(25.15%)
3.62k
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 6.74
(25.05%)
3.3M
EVOEvotec SE
$ 5.07
(-33.73%)
111.7k
TSDDGraniteShares ETF Trust GraniteShares
$ 26.50
(-25.35%)
22.02k
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 41.85
(-25.16%)
283k
ESCAEscalade Inc
$ 10.35
(-24.78%)
10
CDTGCDT Environmental Technology Investment Holdings Ltd
$ 3.03
(-19.41%)
22
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.253
(66.12%)
9.76M
CYNCYNGN Inc
$ 0.1186
(4.04%)
7.19M
ZPTAZapata Computing Holdings Inc
$ 1.99
(27.56%)
5.11M
PEGYPineapple Energy Inc
$ 0.0589
(4.06%)
4.3M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 6.74
(25.05%)
3.3M

TGTX Discussion

View Posts
Monksdream Monksdream 4 months ago
TGTX new 52 week high
๐Ÿ‘๏ธ0
InspectorBullit InspectorBullit 5 months ago
this should have a very good day tomorrow absent a market meltdown. MS drug par excellence.
๐Ÿ‘๏ธ0
murocman murocman 6 months ago
I would think weโ€™d be close to the bottom here? Almost at a 52 week low!

GLTA,

Murocman
👍️ 1
kld2 kld2 8 months ago
Cheap at these levels. Should see $20 again before long. Friday should be interesting. If script numbers are good, like last Friday, the share price should get a good boost. Half way through Q3. Dumb drop from $21 to $9.
👍️ 1
Max77 Max77 8 months ago
$TGTX CEO Weiss buys 100k shares at 10.13. Now has 12 million shares
👍️ 1
murocman murocman 9 months ago
Barely above pre-approval prices. Unbelievable.

Murocman
👍️ 1
teifhals teifhals 11 months ago
Anyone catch that Genetech is starting to air commercials since they are losing share?
๐Ÿ‘๏ธ0
Rayn_Makr Rayn_Makr 12 months ago
Great call this morning. Nice run today and just the beginning with Europe coming on soon.
After Hours Time (ET) After Hours Price After Hours Share Volume
17:27:17 $30.5 5,000
$152,500 in one trade. Short covering???
Fun to think about market cap in 2024 and 2025.
๐Ÿ‘๏ธ0
Alan Brown Alan Brown 1 year ago
Where did you find such news?
๐Ÿ‘๏ธ0
Aquahoya Aquahoya 1 year ago
Has anyone checked out $GSTC? Similar biotech company like $TGTX except its much newer and has a patented formulation combinational therapy already FDA approved set and waiting for clinical trial approval in India for Multiple Sclerosis. It is an over-the-counter stock sitting over .01 just waiting for clinical trials approval. The market cap is on $8,000,000. The therapy isn't specific to the type of multiple sclerosis. So, the potential here is huge. The conservative market share that was done by seasoned professionals in the space, that is on their presentation is in the BILLIONs. Read the history here: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170524593












๐Ÿ‘๏ธ0
teifhals teifhals 1 year ago
Whens the buyout..?
👍️ 1
Penny chatter Penny chatter 1 year ago
Lol
๐Ÿ‘๏ธ0
hawkshaw812 hawkshaw812 1 year ago
Looks like tuseday is shorting day .
๐Ÿ‘๏ธ0
tw0122 tw0122 1 year ago
They have cash and a better MS drug have the price of Roches. Shorts donโ€™t like
๐Ÿ‘๏ธ0
makinezmoney makinezmoney 1 year ago
$TGTX: Not only that but they must be...............

On the wrong side of the trade.

When you get squeezed on them nards, it never feels good.


No mercy....... TAKE THEM OUT !!!!!!!


GO $TGTX
๐Ÿ‘๏ธ0
tw0122 tw0122 1 year ago
Analysts keep on giving it bad sell ratings.
That must be a good sign. Analysts for the most part just share selling scam artists
๐Ÿ‘๏ธ0
makinezmoney makinezmoney 1 year ago
$TGTX: Slowllyy creeping up..... now 11.50 in PreMarket

If it can do exactly what $KALA just did by going over $45, I'm a happy camper


GOOOOOOOOOOOooooooooooooooooooooooooooo hardddddddddddddddddddd



GO $TGTX
๐Ÿ‘๏ธ0
Ringrock Ringrock 1 year ago
Traded@55.70 Jan 8 โ€˜21โ€ฆ looks like sheโ€™s still got quite a bit togoโ€ฆ
๐Ÿ‘๏ธ0
shamalamadingdong shamalamadingdong 1 year ago
Dosing of first patients in 30 to 45 days from now/going to the market!!
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 1 year ago
$TGTX No offerings on the horizon per CC

$TGTX No offerings on the horizon per CC lfg— Cooway Trades ๐ŸŠ โ›ช๏ธ๐Ÿš€๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ™๐Ÿฝ (@cooway) December 29, 2022
๐Ÿ‘๏ธ0
shamalamadingdong shamalamadingdong 1 year ago
Link to 8;30 webcast/conference call.
https://ir.tgtherapeutics.com/events
๐Ÿ‘๏ธ0
shamalamadingdong shamalamadingdong 1 year ago
Some informative information, pictures of the packaging, disease overview, and more.
https://ml.globenewswire.com/1.0/snippet/1898/eng
๐Ÿ‘๏ธ0
shamalamadingdong shamalamadingdong 1 year ago
TG Therapeutics Announces FDA Approval Of BRIUMVI; Company To Host Conference Call On Thursday, December 29, 2022 At 8:30 Am ET
๐Ÿ‘๏ธ0
airman1 airman1 1 year ago
Given a try; on this one in at 8:47 for a morning was jump !!
See if shorts cover before the weekend ??
๐Ÿ‘๏ธ0
airman1 airman1 1 year ago
Yeah, we may get mm naked! shorts covering tomorrow. Share price may
spike./;)) early GL$$
๐Ÿ‘๏ธ0
tw0122 tw0122 1 year ago
They have cash and they would let the price go much higher before another offering
๐Ÿ‘๏ธ0
tw0122 tw0122 1 year ago
$8.73 after hours On a good note company conference 830am and market makers
๐Ÿ‘๏ธ0
pennyfinder pennyfinder 1 year ago
Probably an offering coming.
๐Ÿ‘๏ธ0
tw0122 tw0122 1 year ago
Unfortunately lots of illegal naked shorts courtesy of Gary G but see what happens next few days as more shorts cover.
Never a easy game kept a few shares
๐Ÿ‘๏ธ0
Cheap Stock Investor Cheap Stock Investor 1 year ago
Damn how low is this going? Not headed in right direction at the moment.
๐Ÿ‘๏ธ0
tw0122 tw0122 1 year ago
MS drug going to make hundreds of millions..

Dec 28 (Reuters) - TG Therapeutics Inc said on Wednesday that the U.S. health regulator had approved its monoclonal antibody for treating patients with relapsing forms of multiple sclerosis, sending its shares up nearly 9% in afternoon trade.

The approval by the U.S. Food and Drug Administration (FDA) widens the number of such drugs available for treating the disorder to three and may help soften the blow to the company's finances from the withdrawal of its lymphatic cancer drug earlier this year.

TG Therapeutics said it was expecting to launch the drug, branded as Brumvi, in the first quarter of 2023, but did not give details on its pricing.

Jefferies analyst Chris Howerton said ahead of the approval that he was expecting the drug to be priced in the range of $30,000 per patient per year. In comparison, Roche's Ocrevus has a current list price of about $68,000 annually.

Multiple sclerosis is a neurological disease in which the immune system attacks the brain cells causing motor disabilities. It affects about 400,000 people in the United States, according to the National Institutes of Health.

Unlike other MS drugs that target T cells, Brumvi belongs to a class of drugs that tackles B cells' role in driving the inflammation that is central to neurological disease.

The approval, which comes with a warning of infusion reactions from the drug, was based on a late-stage study that showed the drug was effective in reducing the annualized relapse rates in patients. (Reporting by Sriparna Roy, Khushi Mandowara and Raghav Mahobe in Bengaluru; Editing by Anil D'Silva and Shailesh Kuber)
๐Ÿ‘๏ธ0
SpaceTimeRift777 SpaceTimeRift777 1 year ago
Nice Pump Moon Market
๐Ÿ‘๏ธ0
tw0122 tw0122 1 year ago
As usual they going to scare folks into
Selling there shares loooks like upper $8s bottom
๐Ÿ‘๏ธ0
tw0122 tw0122 1 year ago
Still holding about 20% regular short interest and then all the illegal naked Gary G approved ones
๐Ÿ‘๏ธ0
makinezmoney makinezmoney 1 year ago
$TGTX: Opens at $11...........


Only the beginning now


GO $TGTX
๐Ÿ‘๏ธ0
tw0122 tw0122 1 year ago
Can be whatever you want if we see $40s..lol
๐Ÿ‘๏ธ0
Imarket13 Imarket13 1 year ago
God damn thought you were a woman this whole time
๐Ÿ‘๏ธ0
makinezmoney makinezmoney 1 year ago
$TGTX: I showered.............

Balls, armpits and buttcrack............. good to go.

Took 2mins


GO $TGTX
๐Ÿ‘๏ธ0
tw0122 tw0122 1 year ago
220pm stand corrected
alfred

@macronewswire
TG THERAPEUTICS (TGTX)TO RESUME TRADING AT 2:20 P.M.
$TGTX
๐Ÿ‘๏ธ0
Imarket13 Imarket13 1 year ago
I'm hearing within the next hour... everyone wins!!
๐Ÿ‘๏ธ0
makinezmoney makinezmoney 1 year ago
$TGTX: Fantastic !!!!!!!!!!!!!


Works for me



GO $TGTX
๐Ÿ‘๏ธ0
tw0122 tw0122 1 year ago
Halted I believe until 830am
Press release tomorrow. Donโ€™t take my word but pretty sure
๐Ÿ‘๏ธ0
makinezmoney makinezmoney 1 year ago
$TGTX: Whats the big deal about PKPH ???

Did they just get an FDA approval like $TGTX ??

GO $TGTX
๐Ÿ‘๏ธ0
makinezmoney makinezmoney 1 year ago
$TGTX: No comment


I hope it doesn't open till tomorrow............. then yer filthy for the next 23hrs



GO $TGTX
๐Ÿ‘๏ธ0
halbroke1 halbroke1 1 year ago
makin..TGTX nice one, Im In !!.Check out pk*ph.., Real cheap
๐Ÿ‘๏ธ0
Imarket13 Imarket13 1 year ago
Well they should be. Clean trading is key
๐Ÿ‘๏ธ0
makinezmoney makinezmoney 1 year ago
$TGTX: Then go do whatever it is you do..........


TGTX doesn't care if you wanna shower.
Stocks arent concerned about your hygiene.


GO $TGTX
๐Ÿ‘๏ธ0
makinezmoney makinezmoney 1 year ago
$TGTX: Remember when TGTX was $55 last year .................


And we didn't have anything like this FIRE news today.


Time to make up for some lost ground, and then some

We'd be at $1 now if it never got approved


GO $TGTX
๐Ÿ‘๏ธ0
Imarket13 Imarket13 1 year ago
I have to take a shower
Want to see it open first
๐Ÿ‘๏ธ0
makinezmoney makinezmoney 1 year ago
$TGTX: When it wants............



Whats the rush ???


GO $TGTX
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock